Therapy of Hepatocellular Carcinoma with Rhenium-188 Lipiodol

E-ISSN： 1874-4729|1|2|87-92

ISSN： 1874-4710

Source： Current Radiopharmaceuticals, Vol.1, Iss.2, 2008-05, pp. : 87-92

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sequential therapy with sunitinib and sorafenib in metastatic hepatocellular carcinoma

By Ahn Hee

Investigational New Drugs, Vol. 30, Iss. 4, 2012-08 ,pp. : 1768-1772

Springer Publishing Company

Access to resources Recommend Favorite

Molecular Genetics and Targeted Therapy in Hepatocellular Carcinoma

Current Cancer Drug Targets, Vol. 16, Iss. 1, 2016-01 ,pp. : 53-70

Bentham Science Publishers

Access to resources Recommend Favorite

Angiogenesis in Hepatocellular Carcinoma: A Potential Target for Chemoprevention and Therapy

Current Cancer Drug Targets, Vol. 12, Iss. 9, 2012-11 ,pp. : 1095-1118

Bentham Science Publishers

Access to resources Recommend Favorite

Rhenium-188: Availability from the 188W/188Re Generator and Status of Current Applications

Current Radiopharmaceuticals, Vol. 5, Iss. 3, 2012-07 ,pp. : 228-243

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular targeted therapy of advanced hepatocellular carcinoma beyond sorafenib

By Yau Thomas Pang Roberta Chan Pierre Poon Ronnie T

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 13, 2010-09 ,pp. : 2187-2198

Informa Healthcare

Access to resources Recommend Favorite